Integrated Diagnostics Holdings Plc Notice of
Results
11 November
2024
(London) Integrated Diagnostics Holdings ("IDH," the "Group," or the "Company"), a leading provider of diagnostic services with operations in
Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia, will publish its
financial statements for the nine-month period ended 30 September
2024 on Thursday, 14 November 2024 at 7:00am (UK).
Analyst and Investor Call
Details
An analyst and investor call will be hosted at 12:00
pm (UK) | 14:00 (Egypt) on Tuesday, 19 November 2024. You can learn
more details and register for the call by clicking on this
link.
For more information about the event, please contact:
amoataz@EFG-HERMES.com
-Ends-
About Integrated Diagnostics Holdings (IDH)
IDH is a leading diagnostics
services provider in the Middle East and Africa offering a broad
range of clinical pathology and radiology tests to patients in
Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The Group's core
brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as
well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al
Mokhtabar Sudan (both in Sudan), and Biolab KSA (Saudi Arabia).
With over 40 years of experience, a long track record for quality
and safety has earned the Company a trusted reputation, as well as
internationally recognised accreditations for its portfolio of over
3,000 diagnostics tests. From its base of 601 branches as of 31
December 2023, IDH served over 8.5 million patients and performed
more than 36.1 million tests in 2023. IDH will continue to add
laboratories through a Hub, Spoke and Spike business model that
provides a scalable platform for efficient expansion. Beyond
organic growth, the Group targets expansion in appealing markets,
including acquisitions in the Middle Eastern, African, and East
Asian markets where its model is well-suited to capitalise on
similar healthcare and consumer trends and capture a significant
share of fragmented markets. IDH has been a Jersey-registered
entity (i) whose shares are admitted to the equity shares
(transition) category (previously, the standard listing segment) of
the Official List of the UK Financial Conduct Authority and
admitted to trading on the main market for listed securities of the
London Stock Exchange (ticker: IDHC) since May 2015.
Contact
Tarek Yehia
Investor Relations
Director
T: +20 (0)2 3332 1126 | M: +20 10
6882 6678 | tarek.yehia@idhcorp.com